
Please try another search
Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels. The company was incorporated in 2012 and is headquartered in Newport Beach, California.
Name | Age | Since | Title |
---|---|---|---|
David N. Gill | 69 | 2018 | Independent Director |
Karah Herdman Parschauer | 46 | 2019 | Independent Director |
Vikram Malik | 62 | 2018 | Independent Chairman of the Board |
David Moatazedi | 47 | 2018 | President, CEO & Director |
Brady Stewart | 49 | 2022 | Independent Director |
Albert G. White | 55 | 2024 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review